208 related articles for article (PubMed ID: 12114447)
21. Blockade of the epidermal growth factor receptor signaling inhibits angiogenesis leading to regression of human renal cell carcinoma growing orthotopically in nude mice.
Kedar D; Baker CH; Killion JJ; Dinney CP; Fidler IJ
Clin Cancer Res; 2002 Nov; 8(11):3592-600. PubMed ID: 12429651
[TBL] [Abstract][Full Text] [Related]
22. Adenoviral-mediated gene therapy of human bladder cancer with antisense interleukin-8.
Inoue K; Wood CG; Slaton JW; Karashima T; Sweeney P; Dinney CP
Oncol Rep; 2001; 8(5):955-64. PubMed ID: 11496299
[TBL] [Abstract][Full Text] [Related]
23. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
[TBL] [Abstract][Full Text] [Related]
24. Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer.
Reinmuth N; Liu W; Fan F; Jung YD; Ahmad SA; Stoeltzing O; Bucana CD; Radinsky R; Ellis LM
Clin Cancer Res; 2002 Oct; 8(10):3259-69. PubMed ID: 12374697
[TBL] [Abstract][Full Text] [Related]
25. Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma.
Lenzi R; Rosenblum M; Verschraegen C; Kudelka AP; Kavanagh JJ; Hicks ME; Lang EA; Nash MA; Levy LB; Garcia ME; Platsoucas CD; Abbruzzese JL; Freedman RS
Clin Cancer Res; 2002 Dec; 8(12):3686-95. PubMed ID: 12473577
[TBL] [Abstract][Full Text] [Related]
26. Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule.
Slaton JW; Perrotte P; Inoue K; Dinney CP; Fidler IJ
Clin Cancer Res; 1999 Oct; 5(10):2726-34. PubMed ID: 10537335
[TBL] [Abstract][Full Text] [Related]
27. Antiproliferative effects of interferon-alphaCon1 on ovarian clear cell adenocarcinoma in vitro and in vivo.
Takemoto Y; Yano H; Momosaki S; Ogasawara S; Nishida N; Kojiro S; Kamura T; Kojiro M
Clin Cancer Res; 2004 Nov; 10(21):7418-26. PubMed ID: 15534119
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
Ciardiello F; Caputo R; Bianco R; Damiano V; Fontanini G; Cuccato S; De Placido S; Bianco AR; Tortora G
Clin Cancer Res; 2001 May; 7(5):1459-65. PubMed ID: 11350918
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of phosphatidylinositol 3'-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.
Hu L; Hofmann J; Lu Y; Mills GB; Jaffe RB
Cancer Res; 2002 Feb; 62(4):1087-92. PubMed ID: 11861387
[TBL] [Abstract][Full Text] [Related]
30. IFN-alpha2b and thalidomide synergistically inhibit tumor-induced angiogenesis.
Bauer JA; Morrison BH; Grane RW; Jacobs BS; Borden EC; Lindner DJ
J Interferon Cytokine Res; 2003 Jan; 23(1):3-10. PubMed ID: 12639293
[TBL] [Abstract][Full Text] [Related]
31. Cellular bases of the antitumor activity of the novel taxane IDN 5109 (BAY59-8862) on hormone-refractory prostate cancer.
Cassinelli G; Lanzi C; Supino R; Pratesi G; Zuco V; Laccabue D; Cuccuru G; Bombardelli E; Zunino F
Clin Cancer Res; 2002 Aug; 8(8):2647-54. PubMed ID: 12171897
[TBL] [Abstract][Full Text] [Related]
32. Combination therapy with paclitaxel and thalidomide inhibits angiogenesis and growth of human colon cancer xenograft in mice.
Fujii T; Tachibana M; Dhar DK; Ueda S; Kinugasa S; Yoshimura H; Kohno H; Nagasue N
Anticancer Res; 2003; 23(3B):2405-11. PubMed ID: 12894521
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.
Landen CN; Lu C; Han LY; Coffman KT; Bruckheimer E; Halder J; Mangala LS; Merritt WM; Lin YG; Gao C; Schmandt R; Kamat AA; Li Y; Thaker P; Gershenson DM; Parikh NU; Gallick GE; Kinch MS; Sood AK
J Natl Cancer Inst; 2006 Nov; 98(21):1558-70. PubMed ID: 17077358
[TBL] [Abstract][Full Text] [Related]
34. Suppression of angiogenesis and therapy of human colon cancer liver metastasis by systemic administration of interferon-alpha.
Ozawa S; Shinohara H; Kanayama HO; Bruns CJ; Bucana CD; Ellis LM; Davis DW; Fidler IJ
Neoplasia; 2001; 3(2):154-64. PubMed ID: 11420751
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous blockade of platelet-derived growth factor-receptor and epidermal growth factor-receptor signaling and systemic administration of paclitaxel as therapy for human prostate cancer metastasis in bone of nude mice.
Kim SJ; Uehara H; Yazici S; Langley RR; He J; Tsan R; Fan D; Killion JJ; Fidler IJ
Cancer Res; 2004 Jun; 64(12):4201-8. PubMed ID: 15205332
[TBL] [Abstract][Full Text] [Related]
36. Bikunin plus paclitaxel markedly reduces tumor burden and ascites in mouse model of ovarian cancer.
Kobayashi H; Yagyu T; Inagaki K; Kondo T; Suzuki M; Kanayama N; Terao T
Int J Cancer; 2004 May; 110(1):134-9. PubMed ID: 15054878
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines.
Avramis IA; Christodoulopoulos G; Suzuki A; Laug WE; Gonzalez-Gomez I; McNamara G; Sausville EA; Avramis VI
Cancer Chemother Pharmacol; 2002 Dec; 50(6):479-89. PubMed ID: 12451475
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice.
Karashima T; Sweeney P; Slaton JW; Kim SJ; Kedar D; Izawa JI; Fan Z; Pettaway C; Hicklin DJ; Shuin T; Dinney CP
Clin Cancer Res; 2002 May; 8(5):1253-64. PubMed ID: 12006546
[TBL] [Abstract][Full Text] [Related]
39. Effects of pegylated interferon α2b on metastasis of hepatocellular carcinoma.
Arakawa Y; Shimada M; Utsunomiya T; Imura S; Morine Y; Ikemoto T
J Surg Res; 2012 Jan; 172(1):95-101. PubMed ID: 20851413
[TBL] [Abstract][Full Text] [Related]
40. Assessment of antiangiogenic effect using 99mTc-EC-endostatin.
Yang DJ; Kim KD; Schechter NR; Yu DF; Wu P; Azhdarinia A; Roach JS; Kalimi SK; Ozaki K; Fogler WE; Bryant JL; Herbst R; Abbruzzes J; Kim EE; Podoloff DA
Cancer Biother Radiopharm; 2002 Apr; 17(2):233-45. PubMed ID: 12030117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
